Magnus Rizell

7PUBLICATIONS
24CO-AUTHORS
Disease surveillanceCardiology (incl. cardiovascular diseases)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 27, 2026
Socioeconomic Inequalities in Receipt of Curative-Intent Treatment and Survival After Surveillance-Detected Hepatocellular Carcinoma: A Nationwide Cohort Study.

|Apr 19, 2025
Non-liver comorbidity in patients with hepatocellular carcinoma and curative treatments - a Swedish national registry study.

Malin Sternby Eilard, Madeleine Helmersson, Magnus Rizell

|Mar 20, 2023
Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial).

Roger Olofsson Bagge, Axel Nelson, Amir Shafazand

|Dec 14, 2021
Evaluation of response in patients with hepatocellular carcinoma treated with intratumoral dendritic cell vaccination using intravoxel incoherent motion (IVIM) MRI and histogram analysis.

Mats Andersson, Oscar Jalnefjord, Mikael Montelius

|Feb 04, 2020
Influence of primary tumour and patient factors on survival in patients undergoing curative resection and treatment for liver metastases from colorectal cancer.

P Scherman, I Syk, E Holmberg

|Jun 13, 2019
A prospective clinical trial on sorafenib treatment of hepatocellular carcinoma before liver transplantation.

Malin Sternby Eilard, Mats Andersson, Peter Naredi

Pageof 2

Frequent Collaborators

5 joint publications

Malin Sternby Eilard

3 joint publications

Peter Naredi

2 joint publications

Erik Holmberg

2 joint publications

Mats Andersson